GASTON PEREZ: Open Payments
NPI 1629188586 · BLUFFTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 36 payments from 14 companies in 2025. Trend: 2023 $1,112 · 2024 $1,225 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $142 |
| AstraZeneca Pharmaceuticals LP | 5 | $102 |
| Novo Nordisk Inc | 4 | $82 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Indivior Inc. | 4 | $67 |
| Dexcom, Inc. | 2 | $60 |
| Amgen Inc. | 2 | $51 |
| Lilly USA, LLC | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Braeburn Inc. | 1 | $31 |
Products named: BREZTRI, Sunosi, Auvelity, REXULTI, SUBLOCADE, Dexcom G6 Transmitter, OTEZLA, Ozempic.
Industry payments across SC — which companies pay providers there.
